Resistance to Targeted Therapies in Breast Cancer

Du sparer 0% ift. normalprisen Spar 0%

Hardback
8-11 hverdage
1.697,95 kr.

Bag om Resistance to Targeted Therapies in Breast Cancer

We present an in-depth description of resistance to targeted therapies in breast cancer. Targeted therapies discussed here include those used to treat ER+ or Her2+ breast cancers (i.e., Tamoxifen or trastuzumab) or those targeting signaling pathways aberrantly activated in triple negative breast cancer (i.e., EGFR and Wnt signaling).

Vis mere

Sprog:
Engelsk

ISBN:
9783319701417

Forlag:
Springer International Publishing AG

Indbinding:
Hardback

Sideantal:
184

Udgivet:
13. december 2017

Udgave:
12017

Vægt:
471 g.

Leveringstid: 8-11 hverdage.
Forventet levering: 12. december 2024

På lager

Forlænget returret til d. 31. januar 2025

Normalpris

BLACK FRIDAY
: :

1.697,95 kr. + Fragt
~~1.697,95 kr.~~

Medlemspris

1.647,95 kr.

Prøv i 30 dage for 45 kr.
Herefter fra 79 kr./md. Ingen binding.

Beskrivelse af Resistance to Targeted Therapies in Breast Cancer

We present an in-depth description of resistance to targeted therapies in breast cancer. Targeted therapies discussed here include those used to treat ER+ or Her2+ breast cancers (i.e., Tamoxifen or trastuzumab) or those targeting signaling pathways aberrantly activated in triple negative breast cancer (i.e., EGFR and Wnt signaling).

Brugerbedømmelser af Resistance to Targeted Therapies in Breast Cancer

Andre købte også..

Find lignende bøger

Bogen Resistance to Targeted Therapies in Breast Cancer findes i følgende kategorier:

Business og læring

Resistance to Targeted Therapies in Breast Cancer - Bog

Beskrivelse af Resistance to Targeted Therapies in Breast Cancer

Brugerbedømmelser af Resistance to Targeted Therapies in Breast Cancer

Gør som tusindvis af andre bogelskere